Just to clarify, when I say "but they can probably skip those and go straight to the FDA" I mean they could probably skip making Announcements about receiving Ethics Approval and about Toxicology Studies. They can't skip the step of seeking Ethics Approval for a Clinical Trial or the step of undertaking Toxicology Studies (which we already know are either happening or complete). They certainly have to do them, but they could just skip Announcing the results of both because, in the end, it is only the IND status outcome which is the real market sensitive outcome.
Cheers
Dave
Imugene is now a $1 Billion Company !!!, page-38
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1917207 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 653942 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |